Related Experiment Videos
Strong opioids for cancer pain
1Pain Relief Foundation's Pain Research Institute, Marie Curie Centre Liverpool, Speke Road, Woolton L25 8QA, UK.
Journal of the Royal Society of Medicine
|February 28, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.
Journal of the Royal Society of Medicine·2026
Competition and equity in NHS specialty training, 2021-2024: longitudinal cohort analysis of protected-characteristic outcomes.
Journal of the Royal Society of Medicine·2026
Industrial action and emergency department attendances in England, 2022-2024: a retrospective multicentre causal mediation analysis.
Journal of the Royal Society of Medicine·2026
Ethnic differences in specialty destinations in UK medicine: a repeated cross-sectional analysis of secondary data.
Journal of the Royal Society of Medicine·2026
Medical screening of elderly heads of state.
Journal of the Royal Society of Medicine·2026
Beyond expansion: workforce absence, administration and the persistence of NHS elective backlogs.
Journal of the Royal Society of Medicine·2026
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026